BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 9736715)

  • 21. Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.
    Fang X; Yu S; Tanyi JL; Lu Y; Woodgett JR; Mills GB
    Mol Cell Biol; 2002 Apr; 22(7):2099-110. PubMed ID: 11884598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
    White DE; Cardiff RD; Dedhar S; Muller WJ
    Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1).
    Dickson LM; Lingohr MK; McCuaig J; Hugl SR; Snow L; Kahn BB; Myers MG; Rhodes CJ
    J Biol Chem; 2001 Jun; 276(24):21110-20. PubMed ID: 11274216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity.
    Bijur GN; Jope RS
    J Neurochem; 2000 Dec; 75(6):2401-8. PubMed ID: 11080191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bifurcation of lipid and protein kinase signals of PI3Kgamma to the protein kinases PKB and MAPK.
    Bondeva T; Pirola L; Bulgarelli-Leva G; Rubio I; Wetzker R; Wymann MP
    Science; 1998 Oct; 282(5387):293-6. PubMed ID: 9765155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H; Mao J; Li L; Wu D
    J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation.
    Rössig L; Badorff C; Holzmann Y; Zeiher AM; Dimmeler S
    J Biol Chem; 2002 Mar; 277(12):9684-9. PubMed ID: 11779850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells.
    Persad S; Attwell S; Gray V; Delcommenne M; Troussard A; Sanghera J; Dedhar S
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3207-12. PubMed ID: 10716737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity.
    Cordes N
    Cancer Res; 2004 Aug; 64(16):5683-92. PubMed ID: 15313908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3beta (GSK-3beta) in vitro.
    Cordes N; van Beuningen D
    Br J Cancer; 2003 May; 88(9):1470-9. PubMed ID: 12778079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin.
    Monick MM; Carter AB; Robeff PK; Flaherty DM; Peterson MW; Hunninghake GW
    J Immunol; 2001 Apr; 166(7):4713-20. PubMed ID: 11254732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway.
    Pap M; Cooper GM
    Mol Cell Biol; 2002 Jan; 22(2):578-86. PubMed ID: 11756553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of glycogen synthase kinase-3beta is down-regulated during transient differentiation of human colon cancer HT-29 cells.
    Tuhackova Z; Sloncova E; Hlavacek J; Sovova V; Velek J
    Oncol Rep; 1999; 6(4):827-32. PubMed ID: 10373664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.
    Gómez del Pulgar T; Velasco G; Guzmán M
    Biochem J; 2000 Apr; 347(Pt 2):369-73. PubMed ID: 10749665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells.
    Hajduch E; Alessi DR; Hemmings BA; Hundal HS
    Diabetes; 1998 Jul; 47(7):1006-13. PubMed ID: 9648821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein beta by modulating Akt and glycogen synthase kinase-3.
    Piwien-Pilipuk G; Van Mater D; Ross SE; MacDougald OA; Schwartz J
    J Biol Chem; 2001 Jun; 276(22):19664-71. PubMed ID: 11278638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.
    Fang X; Yu SX; Lu Y; Bast RC; Woodgett JR; Mills GB
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11960-5. PubMed ID: 11035810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin stimulation of the fatty acid synthase promoter is mediated by the phosphatidylinositol 3-kinase pathway. Involvement of protein kinase B/Akt.
    Wang D; Sul HS
    J Biol Chem; 1998 Sep; 273(39):25420-6. PubMed ID: 9738010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells.
    Ebert AD; Wechselberger C; Frank S; Wallace-Jones B; Seno M; Martinez-Lacaci I; Bianco C; De Santis M; Weitzel HK; Salomon DS
    Cancer Res; 1999 Sep; 59(18):4502-5. PubMed ID: 10493495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.